Literature DB >> 13198006

Serum cholinesterase activity in the normal individual and in people with liver disease.

K KAUFMAN.   

Abstract

Entities:  

Keywords:  BLOOD; CHOLINESTERASE/in blood; LIVER FUNCTION TESTS; LIVER/diseases

Mesh:

Substances:

Year:  1954        PMID: 13198006     DOI: 10.7326/0003-4819-41-3-533

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  9 in total

1.  Methods of determining specific and non-specific cholinesterase in microvolumes of blood.

Authors:  A A POKROVSKII
Journal:  Biull Eksp Biol Med       Date:  1961-11

2.  Pseudocholinesterase in early infancy.

Authors:  H LEHMANN; J COOK; E RYAN
Journal:  Proc R Soc Med       Date:  1957-03

3.  [On the method and clinical importance of cholinesterase determination in the serum].

Authors:  W LANG; G INTSESULOGLU
Journal:  Klin Wochenschr       Date:  1962-03-15

4.  Effect of pre-eclampsia on plasma cholinesterase activity.

Authors:  J R Kambam; S Mouton; S Entman; B V Sastry; B E Smith
Journal:  Can J Anaesth       Date:  1987-09       Impact factor: 5.063

5.  The effect of procainamide on plasma cholinesterase activity.

Authors:  J R Kambam; R J Naukam; B V Sastry
Journal:  Can J Anaesth       Date:  1987-11       Impact factor: 5.063

6.  Effects of administration of an organo-phosphorus compound as an antibilharzial agent, with special reference to plasma cholinesterase.

Authors:  S Hanna; K Basmy; O Selim; S M Shoeb; A Y Awny
Journal:  Br Med J       Date:  1966-06-04

7.  Atracurium and severe hepatic disease: a case report.

Authors:  H K Gyasi; M Naguib
Journal:  Can Anaesth Soc J       Date:  1985-03

8.  An assessment of the value of serum cholinesterase as a liver function test and in the diagnosis of jaundice.

Authors:  W BURNETT
Journal:  Gut       Date:  1960-12       Impact factor: 23.059

9.  Plasma cholinesterase activity in patients during therapy with dexamethasone or prednisone.

Authors:  V Bradamante; E Kunec-Vajić; M Lisić; I Dobrić; I Beus
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.